一種自我錨定的縫合線被設計用于皮膚組織傷口的縫合。這種縫合線已經得到了美國食品藥品管理局的批準。

Quill醫學公司以該公司獲得的新型縫合線工藝為基礎，研制出了一系列組織修復器器具，聚對二氧環已酮縫合線是這個系列中的第一種。四十多位產科醫生或者婦科醫生參加了一項臨床試驗，評估這種新型縫合線在縫合剖腹產切口的能力，該研究涉及195例患者。醫生發現使用新型縫合線比傳統縫合線縫合切口更加方便快捷。

Quill醫學公司執行總裁和總監Matthew Megaro指出：“全球外科醫生每年使用數千萬縫合線來閉合傷口與修補組織，所有這些縫合線都必須打結。而Quill自我錨定縫合線則無需這種耗時而費力的打結過程，對所有的外科醫生和患者都十分有利。”
這種自我錨定的縫合線是由Quill醫學公司主席Gregory Ruff醫學博士發明的，他在杜克大學醫學中心（Duke University Medical Center）外科工作了17年。Quill公司的產品針對普外科、整形外科和美容領域的不同需求。

Self-Anchoring Suture Needs No Knot
A new self-anchoring suture is designed for wound closure of dermal tissue. The suture has been cleared by the U.S. Food and Drug Administration (FDA).
The Barbed Polydioxanone suture is the first in a series of tissue repair devices being developed by Quill Medical, Inc. (Research Triangle Park, NC, USA), based on the company’s patented new suture technology. More than 40 obstetrician/gynecologists participated in a trial involving 195 patients to demonstrate the performance of the suture in closing a cesarian section incision. The doctors found the suture to be easier and faster to use than conventional suture material, the company advises.
“Surgeons worldwide use hundreds of millions of sutures each year to close wounds and repair tissue, all of which are secured with suture knots,” observed Matthew Megaro, president and CEO of Quill Medical. “The Quill self-anchoring suture eliminates painstaking and time-consuming knot-tying, a benefit to nearly all surgeons and patients.”
The self-anchoring suture was invented by Gregory Ruff, M.D., chairman of Quill Medical, who for 17 years was a member of the department of surgery at Duke University Medical Center. Quill’s products target diverse applications in general surgery, orthopedic, and aesthetics fields.